[131I]- and [125I]metaiodobenzylguanidin
β
Marja Rutgers; Corine K.M. Buitenhuis; Martin A. van der Valk; Cees A. Hoefnagel
π
Article
π
2000
π
John Wiley and Sons
π
French
β 389 KB
131 I]Metaiodobenzylguanidine ([ 131 I]MIBG) targeted radiotherapy is effective in debulking childhood neuroblastoma. The high-energy beta-emitter [ 131 I]MIBG is, however, not very well suited to treat submillimeter tumors. The [ 125 I]MIBG emission is more fully absorbed in small target volumes an